PUBLICATION
Selected natural and synthetic retinoids impair CCR7- and CXCR4-dependent cell migration in vitro and in vivo
- Authors
- Villablanca, E.J., Zhou, D., Valentinis, B., Negro, A., Raccosta, L., Mauri, L., Prinetti, A., Sonnino, S., Bordignon, C., Traversari, C., and Russo, V.
- ID
- ZDB-PUB-080610-8
- Date
- 2008
- Source
- Journal of Leukocyte Biology 84(3): 871-879 (Journal)
- Registered Authors
- Keywords
- dendritic cells, chemokine receptors, zebrafish
- MeSH Terms
-
- Cells, Cultured
- Gene Expression Regulation, Developmental
- Embryo, Nonmammalian/cytology
- Embryo, Nonmammalian/drug effects*
- Embryo, Nonmammalian/metabolism
- PubMed
- 18515328 Full text @ J. Leukoc. Biol.
Abstract
Dendritic cell (DC) migration to secondary lymphoid organs is a crucial step to initiate adaptive immune responses. This step requires the expression of a functional CCR7 chemokine receptor on DC undergoing maturation. Here, we show that the natural retinoid 9-cis retinoic acid (9cRA) and the synthetic retinoid fenretinide (4-HPR) specifically inhibit the functional up-regulation of CCR7 on maturing human DCs, without affecting early steps of DC maturation. As a consequence, mature DCs do not migrate in vitro toward the chemokine CCL19. Importantly, 4-HPR and 9cRA by inhibiting the expression of CCR7 on bone marrow-derived murine DCs dampen their in vivo migration to draining lymph nodes. 4-HPR also inhibits the expression of the chemokine receptors CXCR4, therefore, impairing in vitro migration of human DCs to CXCL12 and inhibiting in vivo the CXCR4-dependent migration of the posterior lateral line primordium (PLLp) in zebrafish embryos. Taken together, these data highlight a novel function of retinoids and suggest the possibility of using retinoids to treat inflammatory or autoimmune diseases.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping